nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant interferon: extended follow-up times needed?
|
Thoren, Fredrik B |
|
2011 |
12 |
5 |
p. 419- 1 p. |
artikel |
2 |
Androgen deprivation before prostate radiotherapy: how long is long enough?
|
Parker, Chris |
|
2011 |
12 |
5 |
p. 411-412 2 p. |
artikel |
3 |
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
|
Peyrade, Frédéric |
|
2011 |
12 |
5 |
p. 460-468 9 p. |
artikel |
4 |
Australia to be first country to use plain cigarette packaging
|
Kirby, Tony |
|
2011 |
12 |
5 |
p. 427- 1 p. |
artikel |
5 |
Cancer mortality in Northern Ireland
|
Burki, Talha |
|
2011 |
12 |
5 |
p. 428- 1 p. |
artikel |
6 |
Cervical cancer: balancing obstetrical and oncological outcomes
|
Höckel, Michael |
|
2011 |
12 |
5 |
p. 422- 1 p. |
artikel |
7 |
Cervical cancer: balancing obstetrical and oncological outcomes – Authors' reply
|
Rob, Lukas |
|
2011 |
12 |
5 |
p. 422-423 2 p. |
artikel |
8 |
Definition and classification of cancer cachexia: an international consensus
|
Fearon, Kenneth |
|
2011 |
12 |
5 |
p. 489-495 7 p. |
artikel |
9 |
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)
|
Ballester, Marcos |
|
2011 |
12 |
5 |
p. 469-476 8 p. |
artikel |
10 |
Erratum
|
|
|
2011 |
12 |
5 |
p. 418- 1 p. |
artikel |
11 |
For an operational definition of cachexia
|
Pepersack, Thierry |
|
2011 |
12 |
5 |
p. 423-424 2 p. |
artikel |
12 |
Genetic variants associated with breast-cancer risk
|
Narod, Steven A |
|
2011 |
12 |
5 |
p. 415-416 2 p. |
artikel |
13 |
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence
|
Zhang, Ben |
|
2011 |
12 |
5 |
p. 477-488 12 p. |
artikel |
14 |
Hope for very elderly patients with diffuse large B-cell lymphoma
|
Ribera, Josep-Maria |
|
2011 |
12 |
5 |
p. 412-413 2 p. |
artikel |
15 |
How does TPF improve survival over PF?
|
Pointreau, Yoann |
|
2011 |
12 |
5 |
p. 420-421 2 p. |
artikel |
16 |
How does TPF improve survival over PF?
|
Devisetty, Kiran |
|
2011 |
12 |
5 |
p. 419-420 2 p. |
artikel |
17 |
How does TPF improve survival over PF? – Authors' reply
|
Lorch, Jochen H |
|
2011 |
12 |
5 |
p. 421-422 2 p. |
artikel |
18 |
Japan's nuclear crisis
|
The Lancet Oncology, |
|
2011 |
12 |
5 |
p. 409- 1 p. |
artikel |
19 |
Microbial and viral pathogens in colorectal cancer
|
Collins, Danielle |
|
2011 |
12 |
5 |
p. 504-512 9 p. |
artikel |
20 |
Preventive therapy for breast cancer: a consensus statement
|
Cuzick, Jack |
|
2011 |
12 |
5 |
p. 496-503 8 p. |
artikel |
21 |
Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study
|
Kocken, Mariëlle |
|
2011 |
12 |
5 |
p. 441-450 10 p. |
artikel |
22 |
Sentinel-node biopsy in endometrial cancer: a win–win scenario?
|
Kitchener, Henry C |
|
2011 |
12 |
5 |
p. 413-414 2 p. |
artikel |
23 |
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
|
Denham, James W |
|
2011 |
12 |
5 |
p. 451-459 9 p. |
artikel |
24 |
Smart phones: new clinical tools in oncology?
|
Senior, Kathryn |
|
2011 |
12 |
5 |
p. 429-430 2 p. |
artikel |
25 |
Subcutaneous bortezomib: a step towards optimised drug use
|
Mateos, María-Victoria |
|
2011 |
12 |
5 |
p. 410-411 2 p. |
artikel |
26 |
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
|
Moreau, Philippe |
|
2011 |
12 |
5 |
p. 431-440 10 p. |
artikel |
27 |
UK Government hits the pause button over NHS reforms
|
Holmes, David |
|
2011 |
12 |
5 |
p. 425-426 2 p. |
artikel |
28 |
25 years after Chernobyl: lessons for Japan?
|
Moysich, Kirsten B |
|
2011 |
12 |
5 |
p. 416-418 3 p. |
artikel |